BiotechTube
Home/Indivior PLC/Kris M. Mikkelsen
KM

Kris M. Mikkelsen

Chief Financial Officer

Indivior PLC

Therapeutic Areas

Substance Use DisordersSchizophrenia

Indivior PLC Pipeline

DrugIndicationPhase
RBP-6300 (risperidone)SchizophreniaPhase 3
INV-202Cocaine Use DisorderPhase 2b
SUBLOCADE®Opioid Use DisorderMarketed
PERSERIS®SchizophreniaMarketed

Leadership Team at Indivior PLC

MC
Mark Crossley
Chief Executive Officer
CH
Christian Heidbreder, Ph.D.
Chief Scientific Officer
SO
Shawn O'Brien
Chief Commercial Officer
ML
Michele L. J. Hong
Chief Legal Officer & Corporate Secretary
GJ
Guy J. R. P. Farmer
Non-Executive Chairman of the Board
View full Indivior PLC profile